Found 7 matching trials
Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14
N/ATo validate the ability of the Methacetin Breath Test (MBT) to detect clini...
Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension
PHASE2This is a multicenter, randomized, double-blind, placebo-controlled trial i...
Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation
PHASE2The purpose of the study is to test the safety and effectiveness of IDN-655...
Location
Mayo Clinic Scottsdale
Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis
PHASE2This is a multicenter, double-blind, randomized, placebo-controlled trial i...
Location
University of Alabama at Birmingham
Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF
PHASE2The study will evaluate the pharmacokinetics, pharmacodynamics, safety and ...
Location
University of Alabama at Birmingham
A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients
PHASE2The purpose of this study is to determine if IDN-6556, when given orally, i...
Location
Mayo Clinic Hospital
Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis
PHASE2This is a multicenter, double-blind, randomized, placebo-controlled study t...
Location
The Institute for Liver Health